Evogene stock forecast
Evogene (E3V) Stock Forecast & Price Target
E3V Analyst Ratings
E3V Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Scott Henry | Alliance Global Partners | ₪7.16→₪6.84 | buy | ― | Reiterated | 05/26/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Scott HenryAlliance Global Partners | BuyReiterated₪7.16→₪6.84 | 05/26/26 | ― |
Best Analysts Covering Evogene
Copying OpenAI Biotechnology's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +7.47% per trade.
Copying OpenAI Biotechnology's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +7.47% per trade.
Copying OpenAI Biotechnology's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +7.47% per trade.
E3V Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 0 | 0 | 0 | 0 |
In the current month, E3V has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. E3V average Analyst price target in the past 3 months is ―.
E3V Financial Forecast
E3V Earnings Forecast
Next quarter’s earnings estimate for E3V is -ILS 0.62 with a range of -ILS 0.62 to -ILS 0.62. The previous quarter’s EPS was -ILS 1.95. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
E3V Sales Forecast
Next quarter’s sales forecast for E3V is ILS 1.19M with a range of ILS 1.19M to ILS 1.19M. The previous quarter’s sales results were ILS 1.09M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

